已收盘 03-27 16:00:00 美东时间
-0.335
-1.52%
Gentex missed Q4 revenue estimates as China tariffs pressured sales, but stronger margins and steady demand in key markets supported results.
01-31 00:30
Gentex (NASDAQ:GNTX) is gearing up to announce its quarterly earnings on Friday...
01-30 00:01
Gentex Corporation announced a quarterly cash dividend of $0.12 per share, payable on July 23, 2025, to shareholders of record as of July 9, 2025.
2025-05-28 12:00
Viking Therapeutics received an Overweight rating and a December 2025 price target of $80 from JPMorgan analysts.
2024-09-20 20:46
06:46 AM EDT, 09/04/2024 (MT Newswires) -- Gentex (GNTX) has an average outperform rating and a price target range of $33 to $41, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Eu...
2024-09-04 18:46
VOXX International Form 4 Filing Shows Gentex Bought 3,152,500 Shares Of Stock At An Average Price Of $5/Share
2024-08-27 21:38
Gentex Corp Submitted Preliminary, Non-Binding Proposal To Voxx International Corp's Board On May 31
2024-08-27 21:07